Literature DB >> 24813493

Comparing the performance of the SF-6D and the EQ-5D in different patient groups.

Lara N Ferreira1, Pedro L Ferreira2, Luis N Pereira3.   

Abstract

INTRODUCTION: This research aims to explore the performance of the SF-6D and the EQ-5D in patients suffering from asthma, chronic obstructive pulmonary disease, cataracts, and rheumatoid arthritis. In particular, the aim of this research is twofold: 1) to study the level of agreement between the indexes and the descriptive systems of the dimensions of the SF-6D and the EQ-5D, and 2) to analyze the discriminative ability of the instruments.
MATERIAL AND METHODS: A sample of 643 patients completed both the SF-36v2 and the EQ-5D. The discriminative ability of the instruments was analyzed. Furthermore, the level of agreement between the indexes and the descriptive systems of the dimensions of the SF-6D and the EQ-5D were studied. The level of agreement between instruments was investigated using correlation coefficients and the Bland-Altman plots, while the influence of medical condition and other socio-demographic variables was analyzed using nonparametric tests. Paired-samples tests were used to identify differences between the scores. RESULTS AND DISCUSSION: The results show a strong correlation and agreement between both indexes. Overall, questionnaire indexes differ by medical condition and socio-demographic groups and both instruments are able to discriminate between socio-demographic groups.
CONCLUSION: This study confirmed the hypothesis that the SF-6D generates higher utility values in less healthy individuals. The SF-6D and the EQ-5D seem to perform differently in each of the diseases studied since the descriptive statistics differ between instruments and the level of correlation is not uniform. Results show that the instruments generate different utility values, but there is a strong agreement between both indexes. Thus, the two instruments are not interchangeable and their results cannot be directly comparable.

Entities:  

Mesh:

Year:  2014        PMID: 24813493     DOI: 10.20344/amp.4057

Source DB:  PubMed          Journal:  Acta Med Port        ISSN: 0870-399X


  7 in total

1.  A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.

Authors:  Pedro L Ferreira; Patrícia Antunes; Lara N Ferreira; Luís N Pereira; Juan M Ramos-Goñi
Journal:  Qual Life Res       Date:  2019-06-14       Impact factor: 4.147

2.  Health-Related Quality of Life and Utility Scores of Posttreatment Patients with Gastric Cancer at Different Pathological Stages: A Cross-Sectional Study.

Authors:  Huan Zhang; Chen Sun; Yu Chen; Yan Yuan; Ke Xu; Peipei Lu; Jialin Wang; Nan Zhang
Journal:  J Oncol       Date:  2022-04-23       Impact factor: 4.501

3.  Interchangeability of the EQ-5D and the SF-6D, and comparison of their psychometric properties in a spinal postoperative Spanish population.

Authors:  Carmen Selva-Sevilla; Paula Ferrara; Manuel Gerónimo-Pardo
Journal:  Eur J Health Econ       Date:  2020-02-17

4.  Assessing quality of life of self-reported rheumatic patients.

Authors:  Pedro L Ferreira; Sónia P Gonçalves; Lara N Ferreira; Luis N Pereira; Patrícia Antunes; Nélia Gouveia; Ana Rodrigues; Helena Canhão; Jaime Branco
Journal:  Rheumatol Int       Date:  2016-07-04       Impact factor: 2.631

5.  Psychometric properties of the EQ-5D-5L: a systematic review of the literature.

Authors:  You-Shan Feng; Thomas Kohlmann; Mathieu F Janssen; Ines Buchholz
Journal:  Qual Life Res       Date:  2020-12-07       Impact factor: 4.147

6.  Comparing the performance of the EQ-5D-3L and the EQ-5D-5L in young Portuguese adults.

Authors:  Lara N Ferreira; Pedro L Ferreira; Filipa P Ribeiro; Luis N Pereira
Journal:  Health Qual Life Outcomes       Date:  2016-06-08       Impact factor: 3.186

7.  Assessing the construct validity and responsiveness of Preference-Based Measures (PBMs) in cataract surgery patients.

Authors:  Katie Breheny; William Hollingworth; Rebecca Kandiyali; Padraig Dixon; Abi Loose; Pippa Craggs; Mariusz Grzeda; John Sparrow
Journal:  Qual Life Res       Date:  2020-02-20       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.